Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study

Tumor mutation burden (TMB) is an independent indicator used to select patients sensitive to immunotherapy. The present study aimed to investigate the clinicopathological and molecular characteristics of patients with hypermutant lung cancer to identify an economical, simple and complementary method...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Zhang, Hongbin, Wang, Yuan, Ji, Qiaoxia, Cai, Hongmei, Liang, Xiangcun, Xie, Jiong, Li, Hua, Wang, Jun, Zhu, Guiyun, Tian, Erpeng, Zhu, Lingling, Yuan, Mingming, Chen, Rongrong, Zhao, Min
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933761/
https://ncbi.nlm.nih.gov/pubmed/33692861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12590
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky